Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

China SXT Pharmaceuticals (SXTC) Revenue (2023 - 2024)

Historic Revenue for China SXT Pharmaceuticals (SXTC) over the last 2 years, with Q1 2024 value amounting to -$33486.0.

  • China SXT Pharmaceuticals' Revenue rose 9292.41% to -$33486.0 in Q1 2024 from the same period last year, while for Mar 2024 it was -$33486.0, marking a year-over-year increase of 9292.41%. This contributed to the annual value of $1.7 million for FY2025, which is 972.73% down from last year.
  • Latest data reveals that China SXT Pharmaceuticals reported Revenue of -$33486.0 as of Q1 2024, which was up 9292.41% from -$473237.0 recorded in Q1 2023.
  • China SXT Pharmaceuticals' 5-year Revenue high stood at -$33486.0 for Q1 2024, and its period low was -$473237.0 during Q1 2023.